The first Onmark Vision advisory board meeting was a catalyst for progress. We discussed new therapies, tackled common challenges, and laid the groundwork for success. Together, we'll make a significant impact. I'm here to provide more details about this new exclusive GPO program for retina practices, so please let me know if you would like to learn more. #OnmarkVision
Danyelle Brausen’s Post
More Relevant Posts
-
All right, DeviceTalkers this is my last DeviceTalks Boston video. I swear. If you're already attending, I understand if you don't watch. For those of you still on the fence, there's a few things you should know about #DTBoston which starts WEDNESDAY!!!! (tomorrow really) Just excuse the ...well, the guy making the video. #DtBoston2024 #medtech #medicaldevices #medtechinnovator #medicaldevice #surgicalrobotics #sloppyediting #sloppytalking Stryker Medtronic Intuitive BD Distalmotion Quantum Surgical MedTech Innovator
To view or add a comment, sign in
-
Did you know that our remote service could provide less downtime* for you and your imaging systems? This would mean more uptime, which translates to much-needed time for your patients. If downtime is not an option for you, we would love to be your partner. Just contact your local partner and we can look into remote support suitable for your systems. #Philips #Xray #CT #MR #IGT #RemoteService #PartnerWithPurpose #DXR
To view or add a comment, sign in
-
Relationships (or lack thereof) may be the deciding factor in a business deal. In healthcare--especially when patient outcomes are at stake--you want to be confident that your vendor partners will be there for you if and when you need them. #ophthalpreneurs
Eliminator of spectacles and contact lenses. Innovation-obsessed refractive surgeon. Relentless champion for personalized vision | OPHTHALPRENEUR | The Ophthalmologist Power Lists 2023 & 2024
Price is important in business, but so is the value of strong relationships. Know, like, and trust aren't established overnight and can't be measured in euros and cents. Until about 14 years ago, I was a SCHWIND eye-tech-solutions GmbH user. When the FS200 from Alcon launched, I decided to buy a Refractive Suite. It didn’t make sense to keep two excimers and I certainly didn’t have the space. Nevertheless, despite no longer being their customer, Rolf, Domenic von Planta, and the Schwind team maintained close contact with me. They understood the value of relationships and knew that at some point in time, I would be in the market for another laser. That time has finally come. Thank you, Schwind, for your patience. And thank you to my financial partner Michael B. at Sanoptis for trusting your surgeons and giving us the freedom to choose the products that make the most sense for our patients and our practices. Thank you to all of my ophthalmologist friends who weighed in and shared their opinions, helping me to make this decision. #ophthalpreneurs #privatepractice #ophthalmology #leadership #refractivesurgery #laservisioncorrection
To view or add a comment, sign in
-
Why should ECPs trust HOYA Labs with their VSP lens orders? Let us list the ways! 📝 From lab service rated a 9 out of 10 to rebates galore, there are plenty of reasons to make the switch to HOYA as your lab partner. https://lnkd.in/gzeCsiqu #eyecare #optometry #eyecareprofessionals #HOYAforthevisionaries #HOYAvisioncare #HOYAcares #bridgingthevisiongap
To view or add a comment, sign in
-
This is a simulation! Join our co-founder and CEO Elliot Street as he takes us through our new hyper-realistic multimodality hysteroscopy model - elevating the simulated experience for hysteroscopy. This versatile model can train three procedures in one - fundal block, D&C, and endometrial ablation – each with compatible modules within our #Totum software. With incredible natural haptic feedback l and immersive visuals, trainees will forget they are using a simulator while they hone their technique and take the next step into their journey towards skill mastery in these essential gynaecological procedures. Find out more: www.inovus.org Available from November 8th 2024. #SurgicalTraining #MedicalInnovation #OBGYN #SurgerySimulation #InovusMedical #MedicalEducation Elliot Street, Ross Davies, Matt Stone, Emma O'Hagan, Ben Quinton, Ava Coleman, Benton Huddleston, Holly Redwine, Jake Connell, David Laith Rawaf, MD, Matthew Harris
To view or add a comment, sign in
-
Prospective patients often ask the question why should we select your practice for my surgery? It is an important question and one I think everyone should consider. My response is we have done more Light Adjustable Lens procedures than anyone. We know how to adjust the lens after the procedure to maximize your outcome. We also can provide solid data on past patient results based on our entire patient population.
We’re ringing in that Friday energy with some RxSight HISTORY! 🎉 Dr. Andrew Kopstein of K2 Vision has become the first surgeon to complete 2,500 Light Adjustable Lens implants! To commemorate this milestone, RxSight CEO, Ron Kurtz, Senior VP of Sales, Steve Everly, Director of Professional Education, Lauren Fiscale, Account Manager, Adrienne Hawkins, and Clinical Training Specialist, Valentina Werth, were there to celebrate this monumental achievement with Dr. Kopstein and his team. We’re incredibly grateful for Dr. Kopstein’s continued partnership in bringing the power of adjustability to patients in the Pacific Northwest.
To view or add a comment, sign in
-
Learn the 5 steps for Live-Cell Imaging Wondering how to make really cool Live-Cell videos? Check out this page for tips, and a guide to get you started. https://lnkd.in/gjZNDVhA #Invitrogen #EVOS #OnstageIncubator #Microscopy #LiveCellImaging
To view or add a comment, sign in
-
Learn the 5 steps for Live-Cell Imaging Wondering how to make really cool Live-Cell videos? Check out this page for tips, and a guide to get you started. https://lnkd.in/gjZNDVhA #Invitrogen #EVOS #OnstageIncubator #Microscopy #LiveCellImaging
To view or add a comment, sign in
-
Thank you to all our webinar attendees for a lively debate about our pre-series A financing round on Capital Cell: https://lnkd.in/e_yH_b42 As discussed, this may be the last opportunity for business angels to invest in Open Stent Solution. The next series A round will be geared towards venture capital funds and very likely at higher valuations. Cornelis, our transcatheter mitral valve replacement (TMVR) device, will have undergone further validation by then. Our design promise for mitral valve regurgitation treatment is robustly covered by IP: · Extend treatment to broader ages and anatomies because Cornelis can go through small catheters and has a flexible outer crown · Reduce risks of ventricular blockage and valve leakage because Cornelis’s low profile doesn’t expand towards the ventricle, and the valve has a separate, round, inner crown · Enhance anchoring and resilience vs cardiac constraints thanks to specific features Cornelis valve has shown to work for at least 30 days in animals, which is a long time and means it can work well for longer. TMVR total available market (TAM) is estimated over US$8 million by 2032, with a serviceable obtainable market (SOM) for Cornelis estimated around $US 0.6 million. Please contact me or Marc BESSOLES at Capital Cell with any questions. #investors #medtech #medicaldevice #TMVR #Cornelisvalve
To view or add a comment, sign in